This report offers companies, investors, policymakers, and stakeholders crucial insight into the rich ecosystem of pharmaceuticals, biotech, and healthcare companies in Hong Kong, based on in-depth interviews conducted with leaders and pioneers across the value chain, from government representatives, country managers of the world’s leading biopharmaceutical companies, representatives from local SMEs and service providers, and the leading figures from Hong Kong’s rich network of research and educational institutes.
Vaccines / A First for Serum Institute/PATH-developed 5-in-1 Meningitis Vaccine with Nigeria Roll Out
Nigeria has become the first country to roll out a new meningitis vaccine. The product, a shot able to protect against the five causes of meningococcal meningitis, was developed by…
